Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Avalo Therapeutics (AVTX) Asset Utilization Ratio (2016 - 2025)

Avalo Therapeutics' Asset Utilization Ratio history spans 11 years, with the latest figure at 0.0 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio fell 86.2% year-over-year to 0.0; the TTM value through Dec 2025 reached 0.0, down 86.2%, while the annual FY2025 figure was 0.0, 91.4% down from the prior year.
  • Asset Utilization Ratio reached 0.0 in Q4 2025 per AVTX's latest filing, down from 0.0 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.56 in Q2 2023 to a low of 0.0 in Q4 2025.
  • Average Asset Utilization Ratio over 5 years is 0.14, with a median of 0.08 recorded in 2023.
  • Peak YoY movement for Asset Utilization Ratio: surged 739.91% in 2022, then crashed 98.76% in 2024.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.06 in 2021, then surged by 739.91% to 0.52 in 2022, then crashed by 85.17% to 0.08 in 2023, then plummeted by 95.38% to 0.0 in 2024, then tumbled by 86.2% to 0.0 in 2025.
  • Per Business Quant, the three most recent readings for AVTX's Asset Utilization Ratio are 0.0 (Q4 2025), 0.0 (Q3 2025), and 0.0 (Q2 2025).